Loading...
Chemical structure of LQZ-7F

GC72933

LQZ-7F

Also known as 4-amino-N-(13-oxa-10,12,14,16-tetrazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,8,10,14-heptaen-8-ylimino)-1,2,5-oxadiazole-3-carboxamide

LQZ-7F, a survivin dimerization inhibitor, induces spontaneous apoptosis and synergizes with Docetaxel in prostate cancer cells

ChemicalCAS354543-09-2MW349.26FormulaC14H7N9O3
CAS number
354543-09-2
Molecular weight
349.26
Formula
C14H7N9O3
Solubility
DMSO ： 5 mg/mL (14·32 mM; ultrasonic and warming and heat to 60°C)
InChIKey
VQFGZNKRRJEBMK-UHFFFAOYSA-N
Catalogue number
GC72933
Brand
GLPBIO
Computed properties PubChem CID 1749091 · XLogP 2.2 · TPSA 165 Ų · H-bond donors 2
XLogP
2.2
TPSA
165 Ų
H-bond donors
2
H-bond acceptors
9
Rotatable bonds
2
Heavy atoms
26

SMILES C1=CC=C2C(=C1)C(=C3C2=NC4=NONC4=N3)N=NC(=O)C5=NON=C5N

Computed descriptors from PubChem (CID 1749091), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.